Scott S. Sundseth

6.2k total citations · 2 hit papers
41 papers, 4.9k citations indexed

About

Scott S. Sundseth is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Scott S. Sundseth has authored 41 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Surgery and 11 papers in Physiology. Recurrent topics in Scott S. Sundseth's work include Peroxisome Proliferator-Activated Receptors (9 papers), Lipoproteins and Cardiovascular Health (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Scott S. Sundseth is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (9 papers), Lipoproteins and Cardiovascular Health (8 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Scott S. Sundseth collaborates with scholars based in United States, United Kingdom and Canada. Scott S. Sundseth's co-authors include Steven A. Kliewer, Timothy M. Willson, Jürgen M. Lehmann, David J. Waxman, Peter J. Brown, James M. Lenhard, Cecilia S. Koble, G. Bruce Wisely, Pallavi R. Devchand and Stacey A. Jones and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Scott S. Sundseth

40 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ

1997 1.8k citations Steven A. Kliewer, Scott S. Sundseth et al. profile →
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway

1997 1.0k citations Jürgen M. Lehmann, Steven A. Kliewer et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Scott S. Sundseth

Since Specialization

Citations

This map shows the geographic impact of Scott S. Sundseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott S. Sundseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott S. Sundseth more than expected).

Fields of papers citing papers by Scott S. Sundseth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott S. Sundseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott S. Sundseth. The network helps show where Scott S. Sundseth may publish in the future.

Co-authorship network of co-authors of Scott S. Sundseth

This figure shows the co-authorship network connecting the top 25 collaborators of Scott S. Sundseth. A scholar is included among the top collaborators of Scott S. Sundseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott S. Sundseth. Scott S. Sundseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The International Health Cohorts Consortium (IHCC) advances population health research and genomic discovery 2025 ·Communications Medicine ·John J. Connolly, Scott S. Sundseth, Grant M. Wood, (unknown), Geoffrey S. Ginsburg, Philip Awadalla, Michèle Ramsay, Thomas Keane, Peter Goodhand, Adam S. Butterworth, Håkon Håkonarson	0
2	Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel 2016 ·Journal of the American College of Cardiology ·Jacob A. Doll, Megan L. Neely, Matthew T. Roe, Paul W. Armstrong, Harvey D. White, Dorairaj Prabhakaran, Kenneth J. Winters, Suman Duvvuru, Scott S. Sundseth, Joseph A. Jakubowski, Paul A. Gurbel, Deepak L. Bhatt, E. Magnus Ohman, Keith A.A. Fox	25
3	PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes 2015 ·Journal of Thrombosis and Thrombolysis ·(unknown), Sandra Close, (unknown), Michael Man, (unknown), (unknown), Scott S. Sundseth, (unknown), Jessica Delaney, Jean‐Sébastien Hulot, Sabina A. Murphy, Guillaume Paré, Matthew J. Price, Dirk Sibbing, Tabassome Simon, Dietmar Trenk, Elliott M. Antman, Marc S. Sabatine	22
4	Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients 2014 ·Thrombosis and Haemostasis ·Jean G. Diodati, Jorge F. Saucedo, T. Cardillo, (unknown), (unknown), Mark B. Effron, (unknown), (unknown), (unknown), Scott S. Sundseth, (unknown), Dominick J. Angiolillo	4
5	The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease 2014 ·Thrombosis and Haemostasis ·Thomas O. Bergmeijer, Udaya S. Tantry, Jurriën M. ten Berg, Dominick J. Angiolillo, Stefan James, Tomas Lindahl, Peter J Svensson, Joseph A. Jakubowski, (unknown), (unknown), Scott S. Sundseth, Joseph R. Walker, David S. Small, Brian A. Moser, Kenneth J. Winters, (unknown), Paul A. Gurbel	24
6	Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways 2013 ·Thrombosis and Haemostasis ·(unknown), José Luis Ferreiro, Joseph A. Jakubowski, (unknown), Mark B. Effron, (unknown), Timothy M. Costigan, Scott S. Sundseth, Joseph R. Walker, Jorge F. Saucedo, (unknown), Christoph Varenhorst, Oscar Ö. Braun	15
7	Abstract 11255: PON1 Q192R (rs662) Genetic Variant and Response to Clopidogrel and Prasugrel 2011 ·Circulation ·Jessica L. Mega, Sandra Close, Stephen D. Wiviott, Michael Man, Suman Duvvuru, Joseph R. Walker, Scott S. Sundseth, William L. Macias, Elliott M. Antman, Eugene Braunwald, Marc S. Sabatine	1
8	A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease 2009 ·The Pharmacogenomics Journal ·Allen D. Roses, Michael W. Lutz, Heather Amrine‐Madsen, Ann M. Saunders, Donna G. Crenshaw, Scott S. Sundseth, Matthew J. Huentelman, Kathleen A. Welsh‐Bohmer, Eric M. Reiman	288
9	Pipeline Pharmacogenetics: A Novel Approach to Integrating Pharmacogenetics into Drug Development 2009 ·Current Pharmaceutical Design ·P. Anthony Akkari, (unknown), Donna G. Crenshaw, Iris Grossman, Scott S. Sundseth, Daniel K. Burns, Allen D. Roses	6
10	Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score—the CoLaus Study 2009 ·Diabetologia ·Xu Lin, Kijoung Song, Noha Lim, Xin Yuan, Toby Johnson, Amar Abderrahmani, Péter Vollenweider, Heide A. Stirnadel, Scott S. Sundseth, Eric Lai, Daniel K. Burns, Lefkos Middleton, Allen D. Roses, Paul M. Matthews, Gérard Waeber, Lon R. Cardon, Dawn Waterworth, Vincent Mooser	92
11	Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia 2005 ·Journal of Lipid Research ·Yi Yu, Diego F. Wyszynski, Dawn Waterworth, Steve D. Wilton, Philip J. Barter, Y. Antero Kesäniemi, Robert W. Mahley, Ruth McPherson, Gérard Waeber, Thomas P. Bersot, Qianli Ma, Sanjay Sharma, Douglas S. Montgomery, Lefkos Middleton, Scott S. Sundseth, Vincent Mooser, Scott M. Grundy, Lindsay A. Farrer	36
12	Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project) 2005 ·The American Journal of Cardiology ·Diego F. Wyszynski, Dawn Waterworth, Philip J. Barter, Jonathan Cohen, Y. Antero Kesäniemi, Robert W. Mahley, Ruth McPherson, Gérard Waeber, Thomas P. Bersot, Sanjay Sharma, Val Nolan, Lefkos Middleton, Scott S. Sundseth, Lindsay A. Farrer, Vincent Mooser, Scott M. Grundy	57
13	Articular hypermobility is a protective factor for hand osteoarthritis 2004 ·Arthritis & Rheumatism ·Virginia B. Kraus, Yi‐Ju Li, Eden R. Martin, Joanne M. Jordan, Jordan B. Renner, Michael Doherty, Anthony G. Wilson, R. W. Moskowitz, Marc C. Hochberg, Richard F. Loeser, M. Hooper, Scott S. Sundseth	64
14	The characterization of PPARα ligand drug action in an in vivo model by comprehensive differential gene expression profiling 2001 ·Functional & Integrative Genomics ·Bonnie E. Gould Rothberg, Scott S. Sundseth, Vincent A. DiPippo, Peter J. Brown, Deborah A. Winegar, (unknown), Suresh Shenoy, Jonathan M. Rothberg	14
15	The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction 1999 ·Diabetologia ·James M. Lenhard, Mary E. Lancaster, Mark Paulik, James E. Weiel, Jane G. Binz, Scott S. Sundseth, (unknown), Ruth M. Lightfoot, H. Roger Brown	78
16	Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway breakdown → 1997 ·Journal of Biological Chemistry ·Jürgen M. Lehmann, Steven A. Kliewer, Linda B. Moore, Tracey Smith-Oliver, (unknown), (unknown), Scott S. Sundseth, Deborah A. Winegar, Daniel E. Blanchard, Thomas A. Spencer, Timothy M. Willson	1013
17	Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. 1992 ·Journal of Biological Chemistry ·Scott S. Sundseth, David J. Waxman	179
18	Isolation of insecticide resistance-related forms of cytochrome P-450 from Drosophila melanogaster 1990 ·Biochemical Journal ·Scott S. Sundseth, (unknown), L.C. Waters	19
19	Pituitary Regulation of the Male-Specific Steroid 6β-Hydroxylase P-450 2a (gene product IIIA2) in Adult Rat Liver. Suppressive Influence of Growth Hormone and Thyroxine Acting at a Pretranslational Level 1990 ·Molecular Endocrinology ·David J. Waxman, Prabha A. Ram, (unknown), Gerald A. LeBlanc, John A. Alberta, Joseph J. Morrissey, Scott S. Sundseth	74
20	Monoclonal antibodies to drosophila cytochrome P-450's 1987 ·Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) ·Scott S. Sundseth, Stephen J. Kennel, L.C. Waters	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact